Summary
The prevalence of antibodies to hepatitis C virus (anti-HCV) was studied using a second-generation ELISA test in 121 patients with self-limiting acute hepatitis B, including 63 intravenous drug addicts (IVDA). Within the first month after the onset of illness, 47.1% of the patients were anti-HCV positive, this figure reaching 52.1% six months later. The prevalence in the sixth month was significantly higher in the IVDA (93.6%) than in the non-IVDA (6.9%) (p<0.00001). Among the IVDA, anti-HCV was more frequent in those with (100%) than in those without hepatitis delta virus (HDV) coinfection (84.6%) (p=0.004). Of the 63 anti-HCV positive patients, 36 (57.1%) continued to exhibit abnormal transmainase levels for more than six months, while this was not observed in anti-HCV negative patients. These results show a high prevalence of infection by hepatitis C virus (HCV) in IVDA with acute B hepatitis. As a rule, infection by HCV occurred prior to the hepatitis B infection, although occasionally simultaneous infections were observed. HCV appears to be the agent responsible for chronic liver disease in patients with acute B hepatitis who become HBsAg negative.
Zusammenfassung
Bei 121 Patienten mit akuter, spontan heilender Hepatitis B, unter denen auch 63 intravenös Drogenabhängige waren, wurden mit einem ELISA-Test der zweiten Generation auf Hepatitis C-Virus-Antikörper untersucht. Im ersten Monat nach Krankheitsbeginn waren 47,1% der Patienten anti-HCV-positiv, sechs Monate später 52,1%. Bei den intravenös Drogenabhängigen war die Antikörperprävalenz nach sechs Monaten mit 93,6% signifikant höher als bei den nicht Drogenabhängigen (6,9%; p=0,00001). Drogenabhängige mit Koinfektion durch Hepatitis Delta-Virus waren zu 100% anti-HCV-positiv, ohne Delta Virus-Infektion zu 84,6% (p=0,004). Bei 36 der 63 anti-HCV-positiven Patienten (57,1%) waren länger als sechs Monate pathologisch erhöhte Transaminasenspiegel festzustellen. Bei anti-HCV- negativen Patienten war dies nicht der Fall. Diese Ergebnisse belegen, daß bei intravenös Drogenabhängigen mit akuter Hepatitis B häufig eine HCV- Infektion vorliegt. Bei den meisten war die HCV-Infektion vor der B-Hepatitis aufgetreten, in einigen Fällen war eine simultane Infektion festzustellen. HCV scheint für die chronische Lebererkrankung bei Patienten mit akuter B- Hepatitis, die HBsAg-negativ werden, verantwortlich zu sein.
Similar content being viewed by others
References
Dienstag, J. L. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 85 (1983) 439–462.
Liaw, Y.-F., Chu, C.-M., Chang-Chien, C.-S., Wu, C.-S. Simultaneous acute infections with hepatitis non-A, non-B and B viruses. Dig. Dis. Sci. 27 (1982) 762–764.
Mosley, J. W., Redeker, A. G., Feinstone, S. M., Purcell, R. H. Multiple hepatitis viruses in multiple attacks of acute viral hepatitis. N. Engl. J. Med. 296 (1977) 75–78.
Norkrans, G., Frösner, G., Hermodsson, S., Iwarson, S. Multiple hepatitis attacks in drug addicts. JAMA 243 (1980) 1056–1058.
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., Houghton, M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244 (1989) 359–362.
Kuo, G., Choo, Q.-L., Alter, H. J., Gitnick, G. L., Redeker, A. G., Purcell, R. H., Miyamura, T., Dienstag, J. L., Alter, M. J., Stevens, C. E., Tegtmeier, G. E., Bonino, F., Colombo, M., Lee, W. S., Kuo, C., Berger, K., Shuster, J. R., Overby, L. R., Bradley, D. W., Houghton, M. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244 (1989) 359–362.
Alter, H. J., Purcell, R. H., Shih, J. W., Melpolder, J. C., Houghton, M., Choo, Q.-L., Kuo, G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 321 (1989) 1494–1500.
Rodríguez, M., Riestra, S., San Román, F., Pérez, R., Suárez, A., Sánchez, J. L., Rodrigo, L. Prevalence of antibody to hepatitis C virus in prospectively followed acute non-A, non-B hepatitis, from different epidemiological categories. Liver 11 (1991) 129–133.
McHutchinson, J. G., Person, J. L., Govindarajan, S., Valinluck, B., Gore, T., Lee, S. R., Nelles, M., Polito, A., Chien, D., DiNello, R., Quan, S., Kuo, G., Redeker, A. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 15 (1992) 19–25.
Rodríguez, M., Rodrigo, L., Tévar, F. Second-generation tests for hepatitis C virus. Ann. Intern. Med. 115 (1991) 747.
Mosley, J. W., Aach, R. D., Hollinger, F. B., Stevens, C. E., Barbosa, L. H., Nemo, G. J., Holland, P. V., Bancroft, W. H., Zimmerman, H. J., Kuo, G., Choo, Q.-L., Houghton, M. Non-A, non-B hepatitis and antibody to hepatitis C virus. JAMA 263 (1990) 77–78.
Fong, T.-L., Di Biscegli, A. M., Waggoner, J. G., Banks, S. M., Hoofnagle, J. H. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 14 (1991) 64–67.
Fattovich, G., Tagger, A., Brollo, L., Giustina, G., Pontisso, P., Realdi, G., Alberti, A., Ruol, A. Hepatitis C virus infection in chronic hepatitis B virus carriers. J. Infect. Dis. 163 (1991) 400–402.
Esteban, J. I., López-Talavera, J. C., Genescá, J., Madoz, P., Viladomiu, L., Muñiz, E., Martín-Vega, C., Rosell, M., Allende, H., Vidal, X., González, A., Hernández, J. M., Esteban, R., Guardia, J. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann. Intern. Med. 115 (1991) 443–449.
Mortimer, P. P., Cohen, B. J., Litton, P. A., Vandervelde, E. M., Bassendine, M. F., Brind, A. M., Hambling, M. H. Hepatitis C virus antibody. Lancet ii (1989) 798.
Tanaka, E., Kiyosawa, K., Sodeyama, T., Nakano, Y., Yoshizawa, K., Hayata, T., Shimizu, S., Nakatsuji, Y., Koike, Y., Furuta, S. Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B posttransfusion hepatitis. J. Med. Virol. 33 (1991) 117–122.
Esteban, J. I., Esteban, R., Viladomiu, L., López-Talavera, J. C., González, A., Hernández, J. M., Roget, M., Vargas, V., Genesca, J., Buti, M., Guardia, J. Hepatitis C virus antibodies among risk groups in Spain. Lancet ii (1989) 294–297.
Bortolotti, F., Bertaggia, A., Cadrobbi, P., Crivellaro, C., Pornaro, E., Realdi, G. Epidemiological aspects of acute viral hepatitis in drug abusers. Infection 10 (1982) 277–279.
Makris, M., Preston, F. E., Triger, D. R., Underwood, J. C. E., Choo, Q.-L., Kuo, G., Houghton, M. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 335 (1990) 1117–1119.
Chen, D. S., Kuo, G., Sung, J.-L., Lai, M.-Y., Sheu, J.-C., Chen, P.-J., Yang, P.-M., Hsu, H.-M., Chang, M.-H., Chen, C.-J., Hahn, L.-C., Choo, Q.-L., Wang, T. H., Houghton, M. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J. Infect. Dis. 162 (1990) 817–822.
Gaeta, G. B., Rapicetta, M., Sadaro, C., Spadaro, A., Chionne, F., Freni, A. M., Ajello, A., Constantino, A., Giusti, G. Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections. Infection 18 (1990) 277–279.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rodríguez, M., Navascués, C.A., Suárez, A. et al. Hepatitis C virus infection in patients with acute hepatitis B. Infection 20, 316–319 (1992). https://doi.org/10.1007/BF01710674
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01710674